Cargando…

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism

Mostrar otras versiones (1)

The receptor binding domain (RBD) of the spike glycoprotein of the coronavirus SARS‐CoV‐2 (CoV2‐S) binds to the human angiotensin‐converting enzyme 2 (ACE2) representing the initial contact point for leveraging the infection cascade. We used an automated selection process and identified an aptamer t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitz, Anton, Weber, Anna, Bayin, Mehtap, Breuers, Stefan, Fieberg, Volkmar, Famulok, Michael, Mayer, Günter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251191/ https://www.ncbi.nlm.nih.gov/pubmed/33683787 http://dx.doi.org/10.1002/anie.202100316

Ejemplares similares

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism
por: Schmitz, Anton, et al.
Publicado: (2021)

Robotic assisted generation of 2′-deoxy-2′-fluoro-modifed RNA aptamers – High performance enabling strategies in aptamer selection
por: Breuers, Stefan, et al.
Publicado: (2019)

DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach
por: Silwal, Achut Prasad, et al.
Publicado: (2022)

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1
por: Yang, Ge, et al.
Publicado: (2021)

SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD
por: Septisetyani, Endah Puji, et al.
Publicado: (2021)

Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection
por: Wang, Zeng, et al.
Publicado: (2023)

Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants
por: Mi, Taotao, et al.
Publicado: (2022)

Inhibition of HIV-1 subtype C by 2’F-RNA aptamers isolated against enveloped pseudovirus
por: London, GG, et al.
Publicado: (2012)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
por: Yu, Jingyou, et al.
Publicado: (2021)

A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
por: Dadonaite, Bernadeta, et al.
Publicado: (2023)

A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
por: Dadonaite, Bernadeta, et al.
Publicado: (2022)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
por: Sanyal, Dwipanjan, et al.
Publicado: (2022)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
por: Barton, Michael I, et al.
Publicado: (2021)

DNA aptamer selection for SARS-CoV-2 spike glycoprotein detection
por: Martínez-Roque, Mateo Alejandro, et al.
Publicado: (2022)

Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants
por: Yang, Chee-Hing, et al.
Publicado: (2021)

Computer aided prediction and identification of potential epitopes in the receptor binding domain (RBD) of spike (S) glycoprotein of MERS-CoV
por: ali, Mohammad Tuhin, et al.
Publicado: (2014)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
por: Lang, Jianshe, et al.
Publicado: (2011)

Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
por: Sim, Kyu-Young, et al.
Publicado: (2022)

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
por: Cleri, Fabrizio, et al.
Publicado: (2021)

Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses
por: Su, Siyuan, et al.
Publicado: (2021)

Pseudoviruses for the assessment of coronavirus disinfection by ozone
por: Zucker, Ines, et al.
Publicado: (2021)

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
por: Lu, Lu, et al.
Publicado: (2021)

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
por: Han, Pengcheng, et al.
Publicado: (2022)

Low-Entropy Hydration Shells at the Spike RBD’s Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants
por: Yang, Lin, et al.
Publicado: (2023)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes
por: Kalkeri, Raj, et al.
Publicado: (2021)

SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner
por: Zhou, Yun-Qi, et al.
Publicado: (2022)

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity
por: He, Sijia, et al.
Publicado: (2020)

The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
por: Semenov, Valentin A., et al.
Publicado: (2022)

Molecular dynamics study on the strengthening behavior of Delta and Omicron SARS-CoV-2 spike RBD improved receptor-binding affinity
por: Kodchakorn, Kanchanok, et al.
Publicado: (2022)

Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
por: Nagar, Gaurav, et al.
Publicado: (2023)

Selection and Biosensor Application of Aptamers for Small Molecules
por: Pfeiffer, Franziska, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_al3ahbm7b7369ikgcts34lngbh